Election to AIMBE’s College of Fellows is limited to the top 2% of medical and biological engineers in these fields. Those elected are considered to have made outstanding contributions to engineering and medicine research, practice or education. Congratulations to Dr. Ting Wang for being inducted as an AIMBE fellow.
In the new paper published in Nature Reviews, “Towards targeting transposable elements for cancer therapy”, graduate students Xuan Qu and Yonghao Liang (Holden) summarized the latest research developments in the field. In this video, they talk about their research focus in Dr. Ting Wang’s lab.
The Genetics Department at Washington University coordinates the effort of hosting meetings of National Human Genome Research Institute (NHGRI)-funded consortia. The consortia meetings span 5 days from 9.11 – 9.16 and took place on Washington University School of Medicine campus.
The National Institutes of Health (NIH) is channeling $50.3 million over the next five years into a new consortium dedicated to advancing the generation and analysis of multi-omics data for human health research.
Ting Wang, PhD, a national leader in genetics and genomics who has led groundbreaking studies in how the genome is regulated, has been named head of the Department of Genetics at Washington University School of Medicine in St. Louis. A computational biologist, he will begin his new role Aug. 1.
Washington University School of Medicine in St. Louis serves as the national coordinating center for the program, called the Human Pangenome Reference Consortium.
Jumping genes, which scientists call transposable elements, are short sections of the DNA sequence that have been incorporated randomly into the genome over the long course of human evolution. The evolutionary histories of jumping genes are the subject of much current research, but viral infection is thought to play an important role in their origins.
Researchers led by Ting Wang the Sanford C. and Karen P. Loewentheil Distinguished Professor of Medicine, have plumbed genomic databases, looking specifically for tumors whose jumping genes are driving cancer growth.